Interim analysis 31 32 One interim analysis was planned and conducted to examine the efficacy of ISTp-DP versus 33 IPTp-SP, with the plan to stop the ISTp-DP arm only (not the whole trial) if ISTp-DP is the ISTp-DP arm was not stopped. The final analyses were tested at a significance level of 43 0.025 -0.000824 = 0.024176 to decide whether or not we rejected the respective null 44 hypotheses for the comparison between ISTp-DP and IPTp-SP using a 2-sided p-value.
While the primary malaria infection endpoint excluded PCR and past infections by histology, 48 secondary malaria infection endpoints included consideration of PCR and past infections, the 49 latter defined as malaria pigment in the absence of parasites on histology.
50

Morbidity endpoints 51
Birthweight data 52 The aim of the study was to measure birthweight within 24 hours after birth. Birth weights 53 taken 24-48h hours (n= 39, 2.6%), and 48-168 hours after delivery (n= 5, 0.3%) were 54 corrected for the physiological fall in birth weight in breastfed infants occurring in the first 55 days following delivery 1, 2 by a factor +2% and +4%, respectively to obtain the estimated 56 weight at birth. 3, 4 All analyses used corrected birthweight unless indicated otherwise. Low 57 birth weight was defined as <2,500 grams.
58
Gestational age and preterm 59
If more than one gestational age measurement was available we used estimates in the 60 following order of preference: neonatal clinical exam within 96 hours of delivery (Ballard 61 score), last menstrual period (if known), and fundal height at enrolment. Preterm was defined 62 as a gestational age of less than 37 completed weeks.
63
Small for gestational age (SGA)
SGA was defined as birthweight below the tenth percentile for a given gestational age and 65 sex, using a reference population from Tanzania population was used, as ultrasound-based 66 fetal growth charts were not available for Kenyan populations. This also allowed the 67 calculation of Z-scores. 5 
68
Laboratory methods 69 HIV serology was performed by the study health facilities as part of routine ANC profiling. a negative control with no template DNA. All the PCR assays were done from dried blood 92 spot (DBS) on a filter paper following standard operating procedures 10, 11 . The lower 93 detection limit of PCR was 5 parasites/uL of blood. Tissue samples collected from the 94 maternal side of the placenta and fixed with 10% neutral buffered formalin were processed, 95 stained, and examined following standard procedures. 12 Giemsa-stained placental impression 96 smears were read following a standardized protocol. 13 Women were screened for syphilis as congenital malaria, incidence of malaria infection and all-cause sick visits by the mother and 106 infant, and serious adverse events in both the mothers and infants. .0 (2.9--28.0) a includes symptoms which were asked to all women presenting for unscheduled visits b no woman had more than one event within seven days of drug administration, thus number of women is the same as the number of events c incidence rate per 100 person years
